Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Ordinary shares
-
Shares outstanding
-
49.9M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
13.8M
-
Shares change
-
+287K
-
Total reported value, excl. options
-
$538M
-
Value change
-
+$10.2M
-
Number of buys
-
20
-
Number of sells
-
-20
-
Price
-
$39.05
Significant Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q2 2021
50 filings reported holding IMCR - Immunocore Holdings plc - Ordinary shares as of Q2 2021.
Immunocore Holdings plc - Ordinary shares (IMCR) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.8M shares
of 49.9M outstanding shares and own 27.64% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (2.52M shares), Rock Springs Capital Management LP (2.39M shares), RTW INVESTMENTS, LP (1.25M shares), FMR LLC (1.23M shares), BlackRock Inc. (1.08M shares), GENERAL ATLANTIC, L.P. (950K shares), Avidity Partners Management LP (601K shares), Bain Capital Public Equity Management II, LLC (475K shares), PERCEPTIVE ADVISORS LLC (400K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (367K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.